TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Mediverum AB
Closing information (x1000 EUR)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
15
|
18 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
9
|
10 | |
EBITDA |
9
|
11 | |
Total assets |
79
|
93 | |
Current assets |
69
|
85 | |
Current liabilities |
7
|
10 | |
Equity capital |
72
|
82 | |
- share capital |
5
|
4 | |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
91.1%
|
88.2% | |
Turnover per employee |
5
|
6 | |
Profit as a percentage of turnover |
60.0%
|
55.6% | |
Return on assets (ROA) |
11.4%
|
10.8% | |
Current ratio |
985.7%
|
850.0% | |
Return on equity (ROE) |
12.5%
|
12.2% | |
Change turnover |
-3
|
-4 | |
Change turnover % |
-92%
|
-18%
|
-17% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.